Medical Director, Oncology Clinical Development London

At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines, combining our understanding of the immune system with cutting-edge technology to transform people's lives. GSK fosters a culture ambitious for patients, accountable for impact, and committed to doing the right thing, making sure that we focus our efforts on accelerating significant assets that meet patients' needs and have the highest probability of success.

Cancer is unrelenting, but so are we. At GSK, we are committed to transforming outcomes for people with cancer through innovative science, bold ambition, and strong partnerships across the healthcare ecosystem. We focus our science where it can matter most - advancing care in cancers with high unmet need, grounded in a deep understanding of disease biology and deliberate scientific choices that connect discovery to meaningful impact in the real world.

The Medical Director, Oncology Clinical Development is the physician within the clinical program team, bringing medical expertise, clinical judgement, and a patient-centred perspective to the design, conduct, and interpretation of clinical studies. This role is accountable for medical monitoring and safety oversight, ensuring that patient safety and clinical integrity are maintained throughout study execution.

Operating within the clinical strategy defined by the Clinical Development Lead (CDL), the Medical Director partners closely with the Senior Scientist and cross-functional teams to ensure that the physician perspective is fully integrated into study delivery. The role serves as a core member of the Clinical Matrix Team (CMT), contributing to study-level decisions, investigator engagement, and regulatory interactions.

In This Role You Will:

• Serve as the physician within the clinical program team, providing medical expertise across study design, conduct, safety oversight, and data interpretation.
• Lead medical monitoring activities for clinical studies, ensuring patient safety, clinical integrity, and compliance with the protocol and regulatory requirements.
• Interpret clinical and safety data from a physician perspective, generating insights that inform study-level and program-level decisions led by the CDL.
• Partner with the Senior Scientist and cross-functional teams to ensure medical considerations are integrated into study execution and delivery.
• Contribute medical expertise to protocol development, ensuring clinical relevance, patient safety, and feasibility within the framework defined by the CDL.
• Engage with investigators and Key External Experts (KEEs) to support study conduct, scientific exchange, and external representation of the program.
• Contribute to regulatory documents, Health Authority interactions, and scientific communications from a physician perspective.

Detailed Responsibilities:

• Lead medical monitoring activities for assigned clinical studies, including real-time clinical decision-making on patient eligibility, protocol-related medical queries, and safety oversight.
• Conduct and oversee medical review of clinical trial data, both directly and through oversight of delegated medical review activities.
• Interpret and contextualize safety data in collaboration with pharmacovigilance, ensuring appropriate signal detection, escalation, and benefit-risk assessment at the study level.
• Participate in safety review forums, including Safety Review Team (SRT) discussions, Independent Data Monitoring Committee (IDMC) data reviews, and internal governance as required.
• Ensure medical monitoring activities are conducted in compliance with GCP, ICH guidelines, and applicable regulatory frameworks.

Study Design and Execution:

• Provide medical input into protocol development, ensuring clinical relevance, patient safety, and operational feasibility within the clinical strategy defined by the CDL.
• Apply clinical judgement to support protocol implementation, addressing medical questions that arise during study conduct and ensuring consistency with the study’s scientific objectives.
• Partner with the Senior Scientist to ensure that medical considerations are fully integrated into study execution, data generation, and operational delivery.
• Contribute to the development and review of key study documents, including the Informed Consent Form (ICF), protocol deviation management plan (PDMP), and study reference manual (SRM).
• Provide medical input into clinical data generation activities, ensuring alignment with study objectives, patient safety considerations, and the Clinical Development Plan (CDP).

Data Interpretation and Scientific Contribution:

• Interpret clinical data from a physician perspective, translating findings into insights on safety, efficacy, and patient impact that inform decision-making by the CDL.
• Contribute to study-level and program-level data interpretation, supporting the CDL's assessment of benefit-risk and clinical positioning.
• Contribute to the development of scientific communications, including study reports, clinical study summaries, publications, and congress materials.
• Collaborate with investigators on the evaluation and development of abstracts, posters, and manuscripts derived from clinical program data.
• Maintain current knowledge of the asset’s biological mechanism, disease landscape, evolving treatment paradigms, and competitive environment to inform clinical interpretation.

Regulatory and External Engagement:

• Contribute medical expertise to regulatory documents and Health Authority interactions, including responses to clinical and safety queries.
• Support preparation of materials for regulatory submissions, advisory boards, and external engagements, providing the physician perspective on clinical data and safety.
• Engage with Key External Experts (KEEs), investigators, and scientific collaborators to support study conduct, scientific exchange, and relationship development.
• Represent the medical perspective at cross-departmental interactions, including Integrated Evidence Team (IET) and Medical Affairs strategy discussions, as delegated by the CDL.
• Contribute to the clinical and technical diligence assessment of business development opportunities as requested.

Cross-functional Collaboration and Clinical Matrix Team:

• Serve as a core member of the Clinical Matrix Team (CMT), providing medical leadership within study execution.
• Contribute medical expertise to disease area strategy, integrated evidence planning, and Medical Affairs discussions as appropriate.
• Collaborate across functions - including Clinical Operations, Biostatistics, Regulatory, and Pharmacovigilance - to ensure alignment on study objectives, patient safety, and data quality.
• Contribute to Oncology Clinical Development-wide initiatives and workstreams.

Why You?

Working model: This role is hybrid. You will be on-site at one of the posted locations at least two days per week. Remote work is available on other days.

Basic Qualifications: We are seeking professionals with the following required skills and qualifications to help us achieve our goals:

• MD (or equivalent medical degree) with board certification or eligibility in oncology, hematology, or hematology oncology with experience in treating patients with clonal myeloid disorders.
• Clinical experience in oncology and/or relevant therapeutic areas, with direct exposure to clinical research or drug development.
• Experience in clinical trial conduct, including medical monitoring, safety review, and clinical data interpretation.
• Experience leading or supporting clinical development activities in accordance with GCP and ICH guidelines and global regulatory frameworks.
• Experience applying clinical judgement to support study design, patient safety, and real-time medical decision-making within a structured clinical development framework.
• Experience operating effectively within cross-functional matrix teams in a pharmaceutical, biotechnology, or academic clinical trial environment.
• Experience translating clinical data into clear insights for internal and external audiences.

Preferred Qualifications: If you have the following characteristics, it would be a plus:

• Experience in pharmaceutical or biotechnology clinical development across Phase I–III oncology studies.
• Prior experience contributing to regulatory interactions (e.g., IND submissions, scientific advice, NDA/MAA filings).
• Demonstrated experience engaging with Key External Experts (KEEs), investigators, and scientific collaborators in oncology.
• Track record of contributing to clinical publications, congress presentations, or scientific communications.
• Deep understanding of oncology disease biology, evolving treatment paradigms, and the competitive landscape across solid tumors and/or hematological malignancies.
• Experience in medical monitoring across multiple studies or programs within a clinical development organization.